Novanta Inc
NOVT
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.22B
Close$
$30.75
78% downside
Current Fair Value
78% downsideOvervalued by 78% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.22 Billion |
|---|---|
| Enterprise Value | $4.78 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.47 |
| Beta | 1.68 |
| Outstanding Shares | 41,009,000 |
Return
| Return on Equity | 3.82% |
|---|---|
| Return on Assets | 2.89% |
| Return on Invested Capital | 5.35% |
Valuation & Multiples
| P/E Ratio | 92.18 |
|---|---|
| PEG | 51.53 |
| Price to Sales | 5.6 |
| Price to Book Ratio | 3.59 |
| Enterprise Value to Revenue | 4.65 |
| Enterprise Value to EBIT | 47.2 |
| Enterprise Value to Net Income | 77 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$0.83
Average shareholder expectationRevenue Estimate
$262.30 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$0.97
Average shareholder expectationRevenue Estimate
$301.02 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 19.5831▲ 1558.86% |
|---|---|
| Total Calls | 125,200▲ 14.55% |
| Total Puts | 2,451,800▲ 461.57% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 110.59%▲ 10.40% |
|---|---|
| Total Invested | $7.35B▲ 53.81% |
| Investors Holding | 406▲ 63.00% |
ESG Score
No data
About Novanta Inc
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ('OEMs') a competitive advantage. Novanta combines deep proprietary technology expertise and com...